The AGE/RAGE/NF-κB Pathway May Contribute to the Pathogenesis of Polyneuropathy in Impaired Glucose Tolerance (IGT)

Abstract

Binding of ligands to the receptor for advanced glycation end products (RAGE) results in activation of the transcription factor nuclear factor kappa B (NF-κB) and subsequent expression of NF-κB-regulated cytokines. This has been shown to be a relevant pathomechanism in diabetic polyneuropathies (PNP). To determine whether this pathway may contribute to the pathogenesis of PNP due to impaired glucose tolerance (IGT) we performed a pilot study to demonstrate the presence of the RAGE ligand N^ε-(Carboxymethyl)lysine (CML), the receptor itself and NF-κB in sural nerve biopsies of 4 patients with IGT-related PNP. Biopsies of either 4 patients with diabetic PNP and with Charcot-Marie-Tooth disease (CMT) I and II served as positive and negative controls, respectively. In IGT-related PNP and diabetic PNP, CML, RAGE, and NF-κB was found in the perineurium, epineurial vessels and in part in endoneurial vessels. CMT patients showed, if any, only weak staining for one or the other antigen. These data suggest that activation of the RAGE pathway may be one of the first steps in the pathogenesis of PNP even before chronic hyperglycemia occurs.

Key words

Impaired glucose tolerance - polyneuropathies - RAGE - N^ε-(carboxymethyl)lysine - NF-κB

References

• 1 Consensus Panel . Report and recommendations of the San Antonio conference on diabetic neuropathy.  Diabetes Care. 1988;  11 592-597
• 2 Position Statement, American Diabetes Association . Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 2004;  27 5-10
• 3 Bierhaus A, Haslbeck K M, Humpert P M, Liliensiek B, Dehmer T, Morcos M, Sayed A A, Andrassy M, Schiekofer S, Schneider J G, Schulz J B, Heuss D, Neundorfer B, Dierl S, Huber J, Tritschler H, Schmidt A M, Schwaninger M, Haering H U, Schleicher E, Kasper M, Stern D M, Arnold B, Nawroth P P. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.  J Clin Invest. 2004;  114 1741-1751
• 4 Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert P M, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt A M, Stern D M, Haring H U, Schleicher E, Nawroth P P. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.  Diabetes. 2001;  50 2792-2808
• 5 Cordell J L, Falini B, Erber W N, Ghosh A K, Abdulaziz Z, MacDonald S, Pulford K A, Stein H, Mason D Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).  J Histochem Cytochem. 1984;  32 219-229
• 6 Haslbeck K M, Schleicher E D, Friess U, Kirchner A, Neundorfer B, Heuss D. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.  Acta Neuropathol (Berl). 2002;  104 45-52
• 7 Neundörfer B. Klinik und Diagnose der Polyneuropathien.  Dtsch Med Wschr. 1998;  23 1519-1522
• 8 Poduslo J F, Curran G L. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.  Proc Natl Acad Sci U S A. 1992;  89 2218-2222
• 9 Schleicher E D, Wagner E, Nerlich A G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.  J Clin Invest. 1997;  99 457-468
• 10 Singleton J R, Smith A G, Bromberg M B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.  Diabetes Care. 2001;  24 1448-1453
• 11 Singleton J R, Smith A G, Russell J W, Feldman E L. Microvascular complications of impaired glucose tolerance.  Diabetes. 2003;  52 2867-2873
• 12 Sumner C J, Sheth S, Griffin J W, Cornblath D R, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance.  Neurology. 2003;  60 108-111
• 13 Zochodne D W, Cheng C. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin.  Brain Res. 1999;  838 11-17